Titre:
  • The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Auteur:Saussez, Sven; Lorfevre, Francois; Lequeux, Thomas; Laurent, Guy; Chantrain, Gilbert; Vertongen, Françoise; Toubeau, Gérard; Decaestecker, Christine; Kiss, Robert
Informations sur la publication:Oral oncology, 44, 1, page (86-93)
Statut de publication:Publié, 2008-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:ELISA
Galectins-1, -3, -7
Head cancer
Neck cancer
Serum
MeSH keywords:Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell -- diagnosis
Enzyme-Linked Immunosorbent Assay
Feasibility Studies
Female
Galectin 1 -- blood
Galectin 3 -- blood
Galectins -- blood
Head and Neck Neoplasms -- diagnosis
Humans
Male
Middle Aged
Sensitivity and Specificity
Tumor Markers, Biological -- blood
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1368-8375
info:doi/10.1016/j.oraloncology.2006.12.014
info:pii/S1368-8375(07)00014-0
info:scp/37049015985
info:pmid/17350328